A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)
IsraelRecruitingPHASE1, PHASE2
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Conditions
Bladder Cancer · Urinary Bladder Neoplasms
Locations
- Michael G Oefelein Clinical Trials ( Site 0005), Bakersfield, California, United States
- Carolina Urologic Research Center ( Site 0006), Myrtle Beach, South Carolina, United States
- UZ Gent ( Site 0031), Ghent, Oost-Vlaanderen, Belgium
- CHU de Quebec - Hopital de l'Enfant-Jesus ( Site 0011), Québec, Quebec, Canada
- European Interbalkan Medical Center ( Site 0051), Thessaloniki, Greece
- Rabin Medical Center ( Site 0062), Petah Tikva, Israel
- Nederlands Kanker Instituut Antoni van Leeuwenhoek (NKI AVL) ( Site 0081), Amsterdam, North Holland, Netherlands
- Akershus Universitetssykehus ( Site 0091), Lorenskog, Akershus, Norway
- Hospital Universitario Virgen de la Victoria ( Site 0111), Málaga, Andalusia, Spain
- Hospital Universitario 12 de Octubre ( Site 0112), Madrid, Madrid, Comunidad de, Spain
- Ankara University Health Practice and Research Hospitals ( Site 0132), Ankara, Turkey (Türkiye)